Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK8 | P45983 | 20/20 | 0.74 |
| ▸ | MAPK9 | P45984 | 15/20 | 0.74 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.66 |
| ▸ | RPS27 | P42677 | 4/20 | 0.66 |
| ▸ | PRKD2 | Q9BZL6 | 6/20 | 0.63 |
| ▸ | PRKD3 | O94806 | 4/20 | 0.63 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.63 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.63 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.63 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.63 |
| ▸ | CSF1R | P07333 | 5/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.61 |
| ▸ | AKT1 | P31749 | 3/20 | 0.61 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.61 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.61 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.61 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.57 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.57 |
| ▸ | DYRK3 | O43781 | 2/20 | 0.57 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1145329 | 0.89 | MAPK8 (0.74) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL1145277 | 0.86 | MAPK8 (0.75) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL13514197 | 0.86 | MAPK8 (0.83) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL13514498 | 0.85 | MAPK8 (0.68) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL13514223 | 0.82 | MAPK8 (0.76) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL13514233 | 0.82 | MAPK8 (0.74) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL13514253 | 0.81 | MAPK8 (0.72) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL13514091 | 0.80 | MAPK8 (0.73) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL1145860 | 0.80 | MAPK8 (1.00) | MAPK8MAPK9MAPK10RPS27PRKD2 | |
| SCHEMBL1146123 | 0.80 | MAPK8 (0.83) | MAPK8MAPK9MAPK10RPS27PRKD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2375899-B1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF IN THE TREATMENT OF DIABETES | ARRAY BIOPHARMA INC (US) | 2015-02-25 | — | — | EP | disclosed |
| US-8809538-B2 | Piperidine-containing compounds and use thereof | ARRAY BIOPHARMA INC. (US) | 2014-08-19 | — | — | US | disclosed |
| US-20110275608-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2011-11-10 | — | — | US | disclosed |
| EP-2375899-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | Array Biopharma, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| US-7888374-B2 | Inhibitors of c-jun N-terminal kinases | ABBOTT LABORATORIES (US) | 2011-02-15 | — | — | US | disclosed |
| US-7888374-B2 | Inhibitors of c-jun N-terminal kinases | ABBOTT LABORATORIES (US) | 2011-02-15 | — | — | US | disclosed |
| WO-2010080864-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| WO-2010007756-A1 | PYRIDINE DERIVATIVE HAVING TTK INHIBITION ACTIVITY | 塩野義製薬株式会社 (JP) | 2010-01-21 | — | — | WO | disclosed |
| WO-2006083673-A2 | PYRIDINE DERIVATIVES USEFUL AS INHIBITORS OF C-JUN N-TERMINAL KINASES | ABBOTT LABORATORIES (US) | 2006-08-10 | — | — | WO | disclosed |
| US-20060173050-A1 | Inhibitors of c-Jun N-terminal kinases | ABBVIE INC. | 2006-08-03 | — | — | US | disclosed |
| US-20060173050-A1 | Inhibitors of c-Jun N-terminal kinases | ABBVIE INC. | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173050-A1 | Inhibitors of c-Jun N-terminal kinases | MAPKAPK3, MAP3K3, MAPK3 | MAPK8 30/4885MAPK9 49/4885MAPK10 47/4885 |
| US-20110275608-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | NOS1, NOS2, ASS1 | MAPK8 3189/4885MAPK9 1568/4885MAPK10 1352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.